Sökning: onr:"swepub:oai:gup.ub.gu.se/304009" > A population-based ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 09248naa a2200805 4500 | |
001 | oai:gup.ub.gu.se/304009 | |
003 | SwePub | |
008 | 240410s2021 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:oru-90323 | |
009 | oai:DiVA.org:umu-181347 | |
009 | oai:lup.lub.lu.se:ffa06b13-81a3-4d57-afd2-a90cca1eb707 | |
009 | oai:DiVA.org:uu-453864 | |
009 | oai:DiVA.org:liu-174863 | |
009 | oai:prod.swepub.kib.ki.se:146162162 | |
024 | 7 | a https://gup.ub.gu.se/publication/3040092 URI |
024 | 7 | a https://doi.org/10.1080/21681805.2021.18921792 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-903232 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1813472 URI |
024 | 7 | a https://lup.lub.lu.se/record/ffa06b13-81a3-4d57-afd2-a90cca1eb7072 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4538642 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1748632 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1461621622 URI |
040 | a (SwePub)gud (SwePub)orud (SwePub)umud (SwePub)lud (SwePub)uud (SwePub)liud (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Bobjer, Johannesu Lund University,Lunds universitet,Urologi - blåscancer, Malmö,Forskargrupper vid Lunds universitet,Urology - urothelial cancer, Malmö,Lund University Research Groups,Skåne University Hospital,Skåne Univ Hosp, Dept Urol, Jan Waldenströms Gata 5, SE-20502 Malmö, Sweden; Lund Univ, Inst Translat Med, Malmö, Sweden4 aut0 (Swepub:lu)med-jsq |
245 | 1 0 | a A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer |
264 | c 2021-03-06 | |
264 | 1 | b Medical Journals Sweden AB,c 2021 |
500 | a Funding Agencies:Lund Medical Faculty (ALF) Skåne University Hospital Research FundsGyllenstierna Krapperup's Foundation Cancer Research Fund at Malmö General Hospital Stiftelsen Sigurd och Elsa Goljes Minne Bergqvist Foundation Skåne County Council's Research and Development Foundation REGSKANE622351Gösta Jonsson Research Foundation Foundation of Urological Research Hillevi Fries Research Foundation | |
500 | a Funding Agencies|Swedish Cancer SocietySwedish Cancer Society [CAN 2019/62, CAN 2017/278]; Lund Medical Faculty (ALF); Skane University Hospital Research Funds; Gyllenstierna Krapperups Foundation; Cancer Research Fund at Malmo General Hospital; Stiftelsen Sigurd och Elsa Goljes Minne; Bergqvist Foundation; Skane County Councils Research and Development Foundation [REGSKANE622351]; Gosta Jonsson Research Foundation; Foundation of Urological Research; Hillevi Fries Research Foundation | |
520 | a Objective To assess the value of second-look resection (SLR) in stage T1 bladder cancer (BCa) with respect to progression-free survival (PFS), and also the secondary outcomes recurrence-free survival (RFS), bladder-cancer-specific survival (CSS), and cystectomy-free survival (CFS). Patients and methods The study included 2456 patients diagnosed with stage T1 BCa 2004-2009 with 5-yr follow-up registration in the nationwide Bladder Cancer Data Base Sweden (BladderBaSe). PFS, RFS, CSS, and CFS were evaluated in stage T1 BCa patients with or without routine SLR, using univariate and multivariable Cox regression with adjustment for multiple confounders (age, gender, tumour grade, intravesical treatment, hospital volume, comorbidity, and educational level). Results SLR was performed in 642 (26%) individuals, and more frequently on patients who were aged < 75 yr, had grade 3 tumours, and had less comorbidity. There was no association between SLR and PFS (hazard ratio [HR] 1.1, confidence interval [CI] 0.85-1.3), RFS (HR 1.0, CI 0.90-1.2), CFS (HR 1.2, CI 0.95-1.5) or CSS (HR 1.1, CI 0.89-1.4). Conclusions We found similar survival outcomes in patients with and patients without SLR, but our study is likely affected by selection mechanisms. A randomised study defining the role of SLR in stage T1 BCa would be highly relevant to guide current praxis. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Bladder cancer | |
653 | a transurethral resection | |
653 | a second look resection | |
653 | a T1 | |
653 | a Urology & Nephrology | |
653 | a Bladder cancer | |
700 | 1 | a Hagberg, Oskaru Lund University,Lunds universitet,Urologi - blåscancer, Malmö,Forskargrupper vid Lunds universitet,Urology - urothelial cancer, Malmö,Lund University Research Groups,Lund Univ, Inst Translat Med, Malmö, Sweden4 aut0 (Swepub:lu)mats-oha |
700 | 1 | a Abdul-Sattar Aljabery, Firasu Linköpings universitet,Linköping University,Linköping Univ, Div Urol, Dept Clin & Expt Med, Linköping, Sweden,Medicinska fakulteten,Avdelningen för kirurgi, ortopedi och onkologi,Region Östergötland, Urologiska kliniken i Östergötland4 aut0 (Swepub:liu)firab05 |
700 | 1 | a Gardmark, T.u Karolinska Institutet,Karolinska Institute,Danderyd Hospital,Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden4 aut |
700 | 1 | a Jahnson, Staffanu Linköpings universitet,Linköping University,Linköping Univ, Div Urol, Dept Clin & Expt Med, Linköping, Sweden,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland4 aut0 (Swepub:liu)staja74 |
700 | 1 | a Jerlström, Tomas,d 1969-u Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Urology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Örebro Univ, Fac Med & Hlth, Sch Med Sci, Dept Urol, Örebro, Sweden4 aut0 (Swepub:oru)tjm |
700 | 1 | a Sherif, Amiru Umeå University,Umeå universitet,Urologi och andrologi,Umeå Univ, Dept Surg & Perioperat Sci Urol & Androl, Umeå, Sweden4 aut0 (Swepub:umu)amsh0008 |
700 | 1 | a Ströck, Vivekau University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Department of Urology, Sahlgrenska University Hospital and Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden,Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hosp, Dept Urol, Gothenburg, Sweden.;Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden4 aut0 (Swepub:gu)xstrvi |
700 | 1 | a Häggström, Christelu Uppsala universitet,Uppsala University,Endokrinkirurgi,Uppsala Univ, Sweden4 aut0 (Swepub:uu)chrha650 |
700 | 1 | a Holmberg, Larsu Uppsala universitet,Uppsala University,King's College London,Endokrinkirurgi,Kings Coll London, Sch Canc & Pharmaceut Sci, London, England,Uppsala Univ, Sweden; Kings Coll London, England4 aut0 (Swepub:uu)larsholmb |
700 | 1 | a Liedberg, Fredriku Lund University,Lunds universitet,Urologi - blåscancer, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Urology - urothelial cancer, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital,Skåne Univ Hosp, Dept Urol, Jan Waldenströms Gata 5, SE-20502 Malmö, Sweden; Lund Univ, Inst Translat Med, Malmö, Sweden4 aut0 (Swepub:lu)urok-fli |
710 | 2 | a Urologi - blåscancer, Malmöb Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Scandinavian Journal of Urologyd : Medical Journals Sweden ABg 55:2, s. 108-115q 55:2<108-115x 2168-1805x 2168-1813 |
856 | 4 | u https://www.tandfonline.com/doi/pdf/10.1080/21681805.2021.1892179?needAccess=true |
856 | 4 | u https://doi.org/10.1080/21681805.2021.1892179y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1535472/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u http://dx.doi.org/10.1080/21681805.2021.1892179x freey FULLTEXT |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1597204/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1542661/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://gup.ub.gu.se/publication/304009 |
856 | 4 8 | u https://doi.org/10.1080/21681805.2021.1892179 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-90323 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181347 |
856 | 4 8 | u https://lup.lub.lu.se/record/ffa06b13-81a3-4d57-afd2-a90cca1eb707 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-453864 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-174863 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:146162162 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy